389 related articles for article (PubMed ID: 25963186)
1. Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?
Pham KN; Porter CR; Odem-Davis K; Wolff EM; Jeldres C; Wei JT; Morgan TM
J Urol; 2015 Sep; 194(3):674-9. PubMed ID: 25963186
[TBL] [Abstract][Full Text] [Related]
2. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
[TBL] [Abstract][Full Text] [Related]
3. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
[TBL] [Abstract][Full Text] [Related]
4. The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance.
Ayres BE; Montgomery BS; Barber NJ; Pereira N; Langley SE; Denham P; Bott SR
BJU Int; 2012 Apr; 109(8):1170-6. PubMed ID: 21854535
[TBL] [Abstract][Full Text] [Related]
5. Optimization of prostate biopsy in patients considered for active surveillance. The role of the confirmatory biopsy and transperineal techniques.
Fernandez Gomez JM; Garcia Rodriguez J
Arch Esp Urol; 2014 Jun; 67(5):409-18. PubMed ID: 24914840
[TBL] [Abstract][Full Text] [Related]
6. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
Gershman B; Zietman AL; Feldman AS; McDougal WS
Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
[TBL] [Abstract][Full Text] [Related]
7. Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.
Nakai Y; Tanaka N; Anai S; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
BMC Urol; 2017 Apr; 17(1):28. PubMed ID: 28381267
[TBL] [Abstract][Full Text] [Related]
8. Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance.
Meyer AR; Mamawala M; Winoker JS; Landis P; Epstein JI; Macura KJ; Allaf ME; Partin AW; Pavlovich CP; Gorin MA
J Urol; 2021 Apr; 205(4):1069-1074. PubMed ID: 33487007
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
[TBL] [Abstract][Full Text] [Related]
12. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
[TBL] [Abstract][Full Text] [Related]
13. Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System.
Meyer AR; Joice GA; Schwen ZR; Partin AW; Allaf ME; Gorin MA
Urology; 2018 May; 115():8-13. PubMed ID: 29409845
[TBL] [Abstract][Full Text] [Related]
14. Regular transition zone biopsy during active surveillance for prostate cancer may improve detection of pathological progression.
Wong LM; Toi A; Van der Kwast T; Trottier G; Alibhai SM; Timilshina N; Evans A; Zlotta A; Fleshner N; Finelli A
J Urol; 2014 Oct; 192(4):1088-93. PubMed ID: 24742593
[TBL] [Abstract][Full Text] [Related]
15. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
[TBL] [Abstract][Full Text] [Related]
16. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
17. How many cores are enough? Optimizing the transperineal prostate biopsy template.
Schaufler C; Daigle R; Singhaviranon S; Gjertson CK; Albertsen PC; Ristau BT
Urol Oncol; 2022 May; 40(5):191.e1-191.e7. PubMed ID: 35067430
[TBL] [Abstract][Full Text] [Related]
18. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
19. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
Jin BS; Kang SH; Kim DY; Oh HG; Kim CI; Moon GH; Kwon TG; Park JS
Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
[TBL] [Abstract][Full Text] [Related]
20. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
Kasivisvanathan V; Dufour R; Moore CM; Ahmed HU; Abd-Alazeez M; Charman SC; Freeman A; Allen C; Kirkham A; van der Meulen J; Emberton M
J Urol; 2013 Mar; 189(3):860-6. PubMed ID: 23063807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
